Insider Transactions in Q1 2022 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Richard J Hawkins Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-0.02%
|
$1,730
$10.02 P/Share
|
|
Feb 01
2022
|
Richard J Hawkins Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+0.6%
|
$45,000
$10.02 P/Share
|
|
Feb 01
2022
|
David B Karpf Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+4.82%
|
$4,000
$10.02 P/Share
|
|
Feb 01
2022
|
Lori D Lawley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.64%
|
$650
$10.02 P/Share
|
|
Feb 01
2022
|
Lori D Lawley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+8.94%
|
$10,000
$10.02 P/Share
|
|
Feb 01
2022
|
John C. Mc Kew Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-0.31%
|
$1,000
$10.02 P/Share
|
|
Feb 01
2022
|
John C. Mc Kew Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+4.4%
|
$15,000
$10.02 P/Share
|
|
Feb 01
2022
|
Bradley J Powers General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-1.3%
|
$780
$10.02 P/Share
|
|
Feb 01
2022
|
Bradley J Powers General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
900
+13.08%
|
$9,000
$10.02 P/Share
|
|
Feb 01
2022
|
Aaron Schuchart Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-1.29%
|
$520
$10.02 P/Share
|
|
Feb 01
2022
|
Aaron Schuchart Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+19.85%
|
$10,000
$10.02 P/Share
|